Next issueIssue 23 · Tue 17 Nov 

Trials

NCT07420283

Trial ID
T-ctgov-NCT07420283
Registry
ClinicalTrials.gov
NCT number
NCT07420283
Sponsor, as registered
Eli Lilly and Company
Phase
PHASE2
Indication
Opioid Use Disorder
Status
RECRUITING
Start date
2026-02-13
Primary completion
2028-03
Registered countries
Canada, Puerto Rico, United Kingdom, United States
Sites
68

The sponsor's registered location list, which states intent rather than approval.

clinicaltrials.govctgov registryverified 2026-11-07

Notes on the record

Supersedes the row verified 2026-10-19 (kept), per DATA LAYER rule 4. Read live from the ClinicalTrials.gov v2 API 2026-11-07 (https://clinicaltrials.gov/api/v2/studies/NCT07420283); record last update posted 2026-11-04. site_count 61 to 68 location entries; status, dates and the four countries unchanged (no EU member state). Flagged by the collector (inbox/2026-11-05.json); collector proposal replaced by this live read.

Company

Through brenipatide (LY3537031): Lilly

Cited in

No published issue cites this registry number.

Record history